A SOX9-B7x axis safeguards dedifferentiated tumor cells from immune surveillance to drive breast cancer progression-Reference-Cited by-同舟云学术

A SOX9-B7x axis safeguards dedifferentiated tumor cells from immune surveillance to drive breast cancer progression

Published:2023-12 Issue:23 Volume:58 Page:2700-2717.e12
ISSN:1534-5807
Container-title:Developmental Cell
language:en
Short-container-title:Developmental Cell

Author:

Liu Yu,John Peter,Nishitani Kenta,Cui Jihong,Nishimura Christopher D.,Christin John R.,Couturier Nicole,Ren Xiaoxin,Wei Yao,Pulanco Marc C.,Galbo Phillip M.,Zhang Xusheng,Fu Wenyan,Cui Wei,Bartholdy Boris A.,Zheng Deyou,Lauvau Gregoire,Fineberg Susan A.,Oktay Maja H.,Zang Xingxing,Guo Wenjun^ORCID

Publisher

Elsevier BV

Subject

Developmental Biology,Cell Biology,General Biochemistry, Genetics and Molecular Biology,Molecular Biology

Reference80 articles.

1. Improved survival with ipilimumab in patients with metastatic melanoma;Hodi;N. Engl. J. Med.,2010

2. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial;Herbst;Lancet,2016

3. Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer;Reck;N. Engl. J. Med.,2016

4. Atezolizumab and nab-paclitaxel in advanced triple-negative breast cancer;Schmid;N. Engl. J. Med.,2018

5. Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial;Cortes;Lancet,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying subtypes and developing prognostic models based on N6-methyladenosine and immune microenvironment related genes in breast cancer;Scientific Reports;2024-07-18

2. The potential role of CD8+ cytotoxic T lymphocytes and one branch connected with tissue-resident memory in non-luminal breast cancer;PeerJ;2024-07-10

3. Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer;Cancer Research Communications;2024-04-24